Our Story

From the Patient’s Perspective (60 second highlights)

Each year, patients suffer nearly 2 billion dental injections. These injections are stressful for both patients and dentists, and for good reason: The acid preservative in local anesthetic drugs causes pain during injection and a delayed anesthetic effect. For dentists, this means uncomfortable patients, wasted time, and wasted money.

Balanced Pharma is developing a new dental anesthetic designed to eliminate the pain caused by the acidity of standard anesthetics, work right away, and work more reliably.

* Products are currently in development, and are not approved by FDA for sale or distribution.

Please acknowledge the following to continue

I acknowledge that all Balanced Pharma Incorporated (BPI) products are currently in development and have not been evaluated or approved by FDA or any other regulatory body.

Products mentioned on this website are not available for sale, distribution, or use in any jurisdiction.

This website is for accredited investors only.

By continuing, you acknowledge the following: I am an accredited investor as defined by the U.S. Securities and Exchange Commission (SEC).

The information on this website is an overview and does not constitute an offer or invitation for the sale or purchase of securities or any of the businesses or assets described herein. Any BPI products mentioned are in developmental stage, have not been evaluated or approved by FDA or any other regulatory authority, and are not for sale in any jurisdiction or under any circumstance. Contact Balanced Pharma for more updated and detailed information about investment opportunities.